Turnstone BiologicsTSBX
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 47 institutions reported holding Turnstone Biologics Corp. (TSBX) in their 13F filings, up 7 from Q1 2024. 15 opened new positions and 9 sold out. The largest holders were Orbimed Advisors LLC ($8.1M), FMR LLC ($3.0M) and Point72 Asset Management ($2.9M). 3 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Turnstone Biologics Corp.
- CUSIP
- 90042W100
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 15 | $993K |
| Exits | 9 | $235K |
All 13F filers, Q1 2024 → Q2 2024: 821,833 shares bought and 1,477,692 shares sold, net −655,859 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 47 holders
| Orbimed Advisors LLC | 0.16% | No change | 3,099,265 | $8.1M |
| FMR LLC | 0.00% | Reduce -27.9% | 1,135,249 | $3.0M |
| Point72 Asset Management | 0.01% | Reduce -5.5% | 1,118,588 | $2.9M |
| PFM Health Sciences, LP | 0.14% | Add +1.2% | 932,348 | $2.4M |
| Bank of America Corp. | 0.00% | Add +1.3% | 910,781 | $2.4M |
| Takeda Pharmaceutical Co. Ltd. | 1.01% | No change | 895,824 | $2.3M |
| Citadel Advisors | 0.00% | Reduce -0.0% | 684,633 | $1.8M |
| Vanguard Group Inc. | 0.00% | Add +56.6% | 578,995 | $1.5M |
| 72 Investment Holdings, LLC | 3.62% | Reduce 0.0% | 549,980 | $1.4M |
| Sectoral Asset Management Inc. | 0.55% | No change | 517,648 | $1.4M |
| ExodusPoint Capital Management, LP | 0.01% | Add +25.7% | 464,821 | $1.2M |
| Eventide Asset Management, LLC | 0.02% | No change | 458,317 | $1.2M |
| Zimmer Partners, LP | 0.01% | Add +20.7% | 216,138 | $566K |
| FIL Ltd | 0.00% | No change | 192,657 | $505K |
| Millennium Management | 0.00% | New | 125,857 | $330K |
| Barclays PLC | 0.00% | Reduce -4.5% | 115,978 | $304K |
| Northern Trust Corp. | 0.00% | Reduce -5.3% | 94,234 | $247K |
| Goldman Sachs Group Inc. | 0.00% | New | 73,288 | $192K |
| Geode Capital Management, LLC | 0.00% | Reduce -69.8% | 71,952 | $189K |
| Balyasny Asset Management L.P. | 0.00% | Add +63.9% | 53,682 | $141K |
| Susquehanna International Group, LLP | 0.00% | Add +119.5% | 51,293 | $134K |
| Kathleen S. Wright Associates Inc. | 0.05% | No change | 42,553 | $111K |
| BlackRock Inc. | 0.00% | Reduce -93.8% | 41,344 | $108K |
| Jane Street Group, LLC | 0.00% | New | 36,609 | $96K |
| Y-Intercept (Hong Kong) Ltd | 0.01% | New | 35,771 | $94K |
| Centiva Capital, LP | 0.00% | New | 25,225 | $66K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -58.4% | 24,900 | $65K |
| Citigroup Inc. | 0.00% | Add +744.7% | 24,825 | $65K |
| Qube Research & Technologies Ltd | 0.00% | New | 19,025 | $50K |
| Morgan Stanley | 0.00% | Reduce -20.5% | 18,759 | $49K |
| Squarepoint Ops LLC | 0.00% | New | 15,018 | $39K |
| Virtu Financial LLC | 0.00% | New | 13,954 | $37K |
| O'shaughnessy Asset Management, LLC | 0.00% | New | 13,737 | $36K |
| Sei Investments Co. | 0.00% | New | 11,882 | $31K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +208.1% | 10,502 | $28K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | — | 8,135 | $21K |
| JPMorgan Chase & Co. | 0.00% | Add +10.9% | 6,841 | $18K |
| Catalyst Funds Management Pty Ltd | 0.00% | New | 3,900 | $10K |
| Russell Investments Group, Ltd. | 0.00% | New | 2,445 | $6K |
| UBS Group AG | 0.00% | Reduce -91.9% | 1,551 | $4K |
| Nordwand Advisors, LLC | 0.00% | New | 1,500 | $4K |
| Rhumbline Advisers | 0.00% | Reduce -90.6% | 860 | $2K |
| Macquarie Group Ltd. | 0.00% | New | 789 | $2K |
| New York State Common Retirement Fund | 0.00% | Reduce -99.3% | 125 | $328 |
| Nisa Investment Advisors, LLC | 0.00% | Add +80.0% | 54 | $141 |
| Royal Bank of Canada | 0.00% | Reduce -96.9% | 11 | $0 |
| Cwm, LLC | 0.00% | New | 49 | $0 |
"% of holder's portfolio" is TSBX's weight in each manager's 13F, not the share of Turnstone Biologics Corp. the manager owns.